Watchlist Price Alert

Gyre Therapeutics Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

8.26

0.23 (2.86%)

At close: Jun 17, 2025, 10:28 AM

Gyre Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	17.9M	-85.48M	-8.24M	-87.93M	-56.24M	-55.18M	-30.05M	-21.56M	-16.95M
Depreciation & Amortization	1.59M	1.11M	230K	290K	138K	146K	149K	173K	389K
Stock-Based Compensation	831K	7.28M	13.37M	-283.18K	3.63M	3.2M	2.61M	863K	635K
Other Working Capital	n/a	4.22M	541K	-5.39M	-12.87M	20.67M	-1.87M	650K	477K
Other Non-Cash Items	-7.27M	96.68M	-21.48M	3.89M	1.05M	11.42M	116K	18K	-3.39M
Deferred Income Tax	-1M	-1.16M	-838K	-3.89M	-1.05M	-11.42M	n/a	n/a	n/a
Change in Working Capital	-15.69M	7.46M	-4.95M	483K	-2.57M	8.21M	-1.37M	567K	836K
Operating Cash Flow	-3.64M	25.89M	-33.1M	-83.75M	-55.05M	-43.61M	-28.55M	-19.94M	-18.47M
Capital Expenditures	-2.31M	-8.59M	-5M	-839K	-267K	-64K	-376K	-23K	-468K
Cash Acquisitions	n/a	4.02M	55.5M	n/a	-9.93M	-27.46M	n/a	n/a	890K
Purchase of Investments	-15.47M	-15.73M	-50.51M	n/a	-97.64M	-129.98M	-198.91M	-25.47M	-13.4M
Sales Maturities Of Investments	n/a	n/a	57.5M	49.03M	107.56M	157.43M	127.97M	14.3M	10M
Other Investing Acitivies	-2.1M	471K	-2.06M	49.03M	9.93M	27.46M	-70.94M	-57K	2.56M
Investing Cash Flow	-19.88M	-19.76M	55.43M	48.19M	9.66M	27.39M	-71.32M	-11.25M	-1.31M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	-5.08M	-14.32M	-10K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-45.03M	n/a	n/a	n/a	n/a	-3.95M	n/a
Other Financial Acitivies	1.33M	n/a	20K	n/a	n/a	n/a	n/a	18.27M	n/a
Financial Cash Flow	2.1M	2.5M	-45.01M	49.55M	60.38M	327K	111.33M	35.4M	948K
Net Cash Flow	-21.7M	8.33M	-22.68M	13.99M	14.99M	-15.89M	11.46M	4.21M	-18.83M
Free Cash Flow	-5.96M	17.31M	-38.09M	-84.59M	-55.31M	-43.68M	-28.93M	-19.96M	-18.94M